Mass spectrometry and machine learning identify bioactive peptide NHPD-50
A predicted-peptide-variant model trained using mass-spectrometry observations from seven mouse tissues helped prioritize candidate peptides. The authors report that NHPD-50, a secretogranin-1-derived peptide, lowered blood glucose and increased plasma insulin in specified diabetic-mouse experiments. The authors state that the data do not establish the peptide’s exact mechanism. These are early preclinical findings, not a human diabetes treatment; other predicted peptides had different or absent outcomes.
Technology: Predicted-peptide-variant machine-learning prioritization from mass-spectrometry data
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Primary paper reports the stated mouse assay results.
- Still unknown: Independent replication and exhaustive prior-art review are not established; the paper states that the mechanism is undetermined.
- AI role: A predicted-peptide-variant model prioritized candidate sequences from mass-spectrometry data; biological activity was established through subsequent assays.
Evidence sources: https://www.nature.com/articles/s41467-022-34031-z
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 16 Nov 2026. Review scope: Primary Nature full article and bibliographic metadata reviewed for identity, AI role, date, affiliation and bounded mouse results..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.